disopyramide has been researched along with Body Weight in 7 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the hypothyroidism induced by thiamazole on toxic interactions between propranolol and disopyramide were studied in chick embryos." | 7.73 | Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos. ( Kanke, M; Yoshiyama, Y, 2005) |
| "1 Plasma protein binding of disopyramide was determined twice in plasma from seven patients with severe nephrotic syndrome when the disease activity was markedly different for each patient (mean +/- s." | 7.67 | Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases. ( Echizen, H; Ishizaki, T; Saima, S, 1987) |
| "The effect of the hypothyroidism induced by thiamazole on toxic interactions between propranolol and disopyramide were studied in chick embryos." | 3.73 | Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos. ( Kanke, M; Yoshiyama, Y, 2005) |
| "The pharmacokinetics and bioavailability of total (bound plus unbound) and unbound disopyramide were compared following the simultaneous administration of an oral dose of disopyramide and an intravenous dose of 14C-disopyramide in five normal volunteers and in 11 patients with congestive heart failure." | 3.67 | Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide. ( Haughey, DB; Leier, CV; Lima, JJ, 1984) |
| "1 Plasma protein binding of disopyramide was determined twice in plasma from seven patients with severe nephrotic syndrome when the disease activity was markedly different for each patient (mean +/- s." | 3.67 | Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases. ( Echizen, H; Ishizaki, T; Saima, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshiyama, Y | 2 |
| Kanke, M | 2 |
| Lima, JJ | 1 |
| Haughey, DB | 1 |
| Leier, CV | 1 |
| Kumana, CR | 1 |
| Rambihar, VS | 1 |
| Willis, K | 1 |
| Gupta, RN | 1 |
| Tanser, PH | 1 |
| Cairns, JA | 1 |
| Wildeman, RA | 1 |
| Johnston, M | 1 |
| Johnson, AL | 1 |
| Gent, M | 1 |
| Sugiyama, T | 1 |
| Miyazaki, H | 1 |
| Shimada, H | 1 |
| Hasegawa, J | 1 |
| Mori, A | 1 |
| Yamamoto, R | 1 |
| Kinugawa, T | 1 |
| Morisawa, T | 1 |
| Kishimoto, Y | 1 |
| Rao, KS | 1 |
| Stejskal, R | 1 |
| Ferguson, DM | 1 |
| McConnell, RG | 1 |
| Echizen, H | 1 |
| Saima, S | 1 |
| Ishizaki, T | 1 |
1 trial available for disopyramide and Body Weight
| Article | Year |
|---|---|
Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Body Weight; Clinical Trials as Topic; Disopyramide; Double-Blind | 1982 |
6 other studies available for disopyramide and Body Weight
| Article | Year |
|---|---|
Influence of hypothyroidism induced by thiamazole on the toxic interaction between propranolol and disopyramide in chick embryos.
Topics: Animals; Antithyroid Agents; Body Weight; Chick Embryo; Disopyramide; Drug Interactions; Hypothyroid | 2005 |
Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.
Topics: Adult; Aged; Biological Availability; Blood Proteins; Body Weight; Carbon Radioisotopes; Disopyramid | 1984 |
Toxic interactions between disopyramide and propranolol in chick embryos.
Topics: Animals; Anti-Arrhythmia Agents; Body Weight; Chick Embryo; Disopyramide; Drug Interactions; Electro | 1997 |
Disopyramide decreases the fasting serum glucose level in man.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Blood Glucose; Body Weight; Creatinine; Delayed-Action Pr | 1999 |
Toxicological evaluation of Norpace after intravenous administration to rat and dog.
Topics: Animals; Body Weight; Disopyramide; Dogs; Evaluation Studies as Topic; Female; Half-Life; Infusions, | 1977 |
Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.
Topics: Adult; Body Weight; Disopyramide; Female; Humans; Kinetics; Male; Middle Aged; Nephrotic Syndrome; O | 1987 |